TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20610230

Group type: EXPERIMENTAL
Intervention: BB(OFF)
Number of subjects: 17

Group type: COMPARATOR
Intervention: BB(ON)
Number of subjects: 17
Study: 19002337

Group type: EXPERIMENTAL
Intervention: Light-fractionated aminolaevulinic acid photodynamic therapy (PDT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control biopsies
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Ki-67 staining
Number of subjects: 32
Study: 21592741

Group type: EXPERIMENTAL
Intervention: risperidone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: divalproex
Number of subjects: 24

Group type: COMPARATOR
Intervention: healthy controls
Number of subjects: 24
Study: 16198776

Group type: EXPERIMENTAL
Intervention: Continuous-dose terbinafine (250 mg daily for 3 months)
Number of subjects: 306

Group type: COMPARATOR
Intervention: Pulse-dose terbinafine (500 mg daily for 1 week per month for 3 months)
Number of subjects: 306
Study: 11887024

Group type: EXPERIMENTAL
Intervention: Essential amino acids (group B)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Amino acids and vitamins (group C)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Calcium phosphate (control group D)
Number of subjects: 77
Study: 9817939

Group type: EXPERIMENTAL
Intervention: High IL-1beta cytokine production (>/=75th percentile)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Low IL-1beta cytokine production (<75th percentile)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: High IL-6 cytokine production (>/=75th percentile)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Low IL-6 cytokine production (<75th percentile)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: TNF-alpha cytokine production
Number of subjects: 50
Study: 7658278

Group type: EXPERIMENTAL
Intervention: Adenosine 5'-monophosphate bronchial challenge
Number of subjects: 54

Group type: COMPARATOR
Intervention: Methacholine bronchial challenge
Number of subjects: 54
Study: 2759456

Group type: EXPERIMENTAL
Intervention: Experience-based educational intervention (interviewing volunteer nursing home residents)
Number of subjects: 0
Study: 1011909

Group type: EXPERIMENTAL
Intervention: Digital stretching of the anal canal (anal dilatation)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Modified lateral subcutaneous sphincterotomy
Number of subjects: 66
Study: 11809090

Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia
Number of subjects: 14
Study: 31331757

Group type: EXPERIMENTAL
Intervention: IP cefepime monotherapy, 1g/d
Number of subjects: 144

Group type: COMPARATOR
Intervention: IP combination of cefazolin and ceftazidime, 1g/d
Number of subjects: 144
Study: 28926675

Group type: EXPERIMENTAL
Intervention: Higher personal technology usage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher thwarted belongingness
Number of subjects: 0
Study: 26511123

Group type: EXPERIMENTAL
Intervention: Single-Incision Laparoscopic Surgery (SILS)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Laparoscopic Surgery (LS)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Precision Cutting Task
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Peg Transfer Task
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Gender Comparison
Number of subjects: 60
Study: 25449505

Group type: EXPERIMENTAL
Intervention: eGFR group-III (≤ 59 ml/min/1.73 m²)
Number of subjects: 149
Study: 23016708

Group type: EXPERIMENTAL
Intervention: Amiloride
Number of subjects: 70
Study: 20442982

Group type: EXPERIMENTAL
Intervention: Navigated TKA
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional TKA
Number of subjects: 80
Study: 17398308

Group type: EXPERIMENTAL
Intervention: 1800 mg of eicosapentaenoic acid (EPA) daily with statin (EPA group; n=9326)
Number of subjects: 18645

Group type: COMPARATOR
Intervention: Statin only (controls; n=9319)
Number of subjects: 18645

Group type: EXPERIMENTAL
Intervention: EPA treatment in patients with a history of coronary artery disease
Number of subjects: 18645

Group type: EXPERIMENTAL
Intervention: EPA treatment in patients with no history of coronary artery disease
Number of subjects: 18645
Study: 15913007

Group type: EXPERIMENTAL
Intervention: Condition 1: Memorized descriptions of how segments are arranged to form patterns
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Condition 2: Memorized segments and mentally amalgamated them into patterns
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both conditions
Number of subjects: 0
Study: 12612514

Group type: EXPERIMENTAL
Intervention: Immersion technique
Number of subjects: 50

Group type: COMPARATOR
Intervention: Air insufflation alone
Number of subjects: 50
Study: 10475405

Group type: EXPERIMENTAL
Intervention: Nitecapone (50 microM solution in Plegisol)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Crystalloid cardioplegia (Plegisol)
Number of subjects: 30
Study: 8745384

Group type: EXPERIMENTAL
Intervention: Valproic acid, 125 mg twice daily
Number of subjects: 1

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 1
Study: 1716979

Group type: EXPERIMENTAL
Intervention: Cotinine-assisted smoking intervention programme (interpreted measurement of serum cotinine, self-help smoking cessation booklet, repeat serum cotinine measurement one month later)
Number of subjects: 2848

Group type: COMPARATOR
Intervention: Usual anti-smoking advice provided by the antenatal care site
Number of subjects: 2848
Study: 6181617

Group type: EXPERIMENTAL
Intervention: Cyclic somatostatin
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no somatostatin)
Number of subjects: 20
Study: 31424575

Group type: EXPERIMENTAL
Intervention: Limited health literacy (LHL)
Number of subjects: 1400

Group type: EXPERIMENTAL
Intervention: Spanish speakers
Number of subjects: 1400

Group type: EXPERIMENTAL
Intervention: High school education or less
Number of subjects: 1400

Group type: EXPERIMENTAL
Intervention: Nonwhite race
Number of subjects: 1400

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 1400

Group type: EXPERIMENTAL
Intervention: Greater social support
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Prior ACP experience
Number of subjects: 1400
Study: 29508066

Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia (LIA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline (sham LIA)
Number of subjects: 40
Study: 27592224

Group type: EXPERIMENTAL
Intervention: Adaptive servoventilation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Optimum medical treatment for heart failure alone (Control group)
Number of subjects: 0
Study: 25283504

Group type: EXPERIMENTAL
Intervention: Intravenous recombinant urate oxidase (uricase) at doses of 0.1, 0.2, and 0.3 mg/kg; multiple doses of 0.2 mg·kg(‐1)·d(‐1) for 7 days
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intravenous recombinant urate oxidase (uricase)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 23007493

Group type: EXPERIMENTAL
Intervention: Superficial cooling garment (CS)
Number of subjects: 9

Group type: COMPARATOR
Intervention: No cooling (NCS)
Number of subjects: 9
Study: 21119098

Group type: EXPERIMENTAL
Intervention: Pharmaceutical care program (5 individual counseling sessions by a pharmacist over 1 year)
Number of subjects: 899

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 899

Group type: COMPARATOR
Intervention: Both groups (Pharmaceutical care and Usual care)
Number of subjects: 899
Study: 17959976

Group type: EXPERIMENTAL
Intervention: Nonthermosoftened ETTs
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Nonthermosoftened ETTs obturated with an inflated esophageal stethoscope
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Thermosoftened ETTs
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Thermosoftened ETTs obturated with an inflated esophageal stethoscope
Number of subjects: 200
Study: 15877788

Group type: EXPERIMENTAL
Intervention: Octreotide 0.1 mg subcutaneously at the time of operation and 3x/d thereafter until post-operative day 7
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no octreotide)
Number of subjects: 40
Study: 12059898

Group type: EXPERIMENTAL
Intervention: PEEP (1 cmH2O above the pressure at the lower inflexion point, mean 14±3 cmH2O)
Number of subjects: 16

Group type: COMPARATOR
Intervention: ZEEP (no PEEP)
Number of subjects: 16
Study: 9477052

Group type: EXPERIMENTAL
Intervention: Intra-articular neostigmine (500 microg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control groups (intra-articular saline, s.c. neostigmine)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intra-articular neostigmine (125 microg and 250 microg)
Number of subjects: 60
Study: 8583174

Group type: EXPERIMENTAL
Intervention: Intraexaminer reliability for L1-L5 absolute rotation angle
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Intraexaminer reliability for anterior/posterior thorax translation
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Intraexaminer reliability for arcuate angle (AA)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Intraexaminer reliability for Ferguson's angle (FA)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Intraexaminer reliability for relative rotation angles
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Interexaminer reliability for the three examiners
Number of subjects: 3
Study: 2795592

Group type: EXPERIMENTAL
Intervention: Isometric handgrip (IHG)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Bicycle ergometric exercise (BEE)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tyramine infusion (TI)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline (control for TI)
Number of subjects: 40
Study: 346293

Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Trimethoprim/sulfamethoxazole
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Pitressin concentration test
Number of subjects: 22
Study: 30531542

Group type: EXPERIMENTAL
Intervention: Nested Polymerase Chain Reaction (PCR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal skin biopsies (Control)
Number of subjects: 30
Study: 28806982

Group type: EXPERIMENTAL
Intervention: Algorithm-guided blood glucose control (LOGIC-C, n=777)
Number of subjects: 1550
Study: 26429559

Group type: EXPERIMENTAL
Intervention: Memory training workshops (12 sessions, 90 minutes each, once a week)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control group (not participating in memory training workshops)
Number of subjects: 230
Study: 23890768

Group type: EXPERIMENTAL
Intervention: Pemetrexed 500 mg/m² on day 1 plus erlotinib 150 mg daily on days 2-14
Number of subjects: 240

Group type: COMPARATOR
Intervention: Erlotinib 150 mg daily
Number of subjects: 240

Group type: COMPARATOR
Intervention: Pemetrexed 500 mg/m² on day 1
Number of subjects: 240
Study: 21183106

Group type: EXPERIMENTAL
Intervention: Hydrogel bandage
Number of subjects: 316

Group type: COMPARATOR
Intervention: Corneal shield
Number of subjects: 316
Study: 19372532

Group type: EXPERIMENTAL
Intervention: Intervention group (clinic-based, individually tailored counseling sessions)
Number of subjects: 1044

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 1044
Study: 17333123

Group type: COMPARATOR
Intervention: Manual physical therapy (Group 2)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Self-training program (Group 1)
Number of subjects: 30
Study: 15144242

Group type: EXPERIMENTAL
Intervention: Early oral feeding without NG tube (Group B)
Number of subjects: 100

Group type: COMPARATOR
Intervention: NG catheter and fasting until passage of flatus (Group A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 100
Study: 12536650

Group type: EXPERIMENTAL
Intervention: Nylestriol (2 mg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 10545723

Group type: EXPERIMENTAL
Intervention: Bionormalizer 9 g at bedtime and 3 h prior examination
Number of subjects: 22

Group type: COMPARATOR
Intervention: Flavored sugar 9 g as placebo
Number of subjects: 22

Group type: COMPARATOR
Intervention: Ethanol ingestion
Number of subjects: 22
Study: 7589041

Group type: EXPERIMENTAL
Intervention: L-arginine
Number of subjects: 10

Group type: COMPARATOR
Intervention: D-glucose
Number of subjects: 10
Study: 2328301

Group type: EXPERIMENTAL
Intervention: Austyn (sustained-release theophylline capsule) with food
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Austyn (sustained-release theophylline capsule) fasting
Number of subjects: 18

Group type: COMPARATOR
Intervention: Elixophyllin elixir (reference product) fasting
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Austyn capsules (multiple dosing)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Theo-Dur (sustained-release tablet)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Austyn (sustained-release capsule)
Number of subjects: 18
Study: 7211858

Group type: EXPERIMENTAL
Intervention: Pfi‐Lithium (300 mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Eskalith (300 mg)
Number of subjects: 18
Study: 31788006

Group type: COMPARATOR
Intervention: Wright® nebulizer
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Solo® nebulizer
Number of subjects: 18

Group type: COMPARATOR
Intervention: Wright® methacholine
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Solo® methacholine
Number of subjects: 18
Study: 27906684

Group type: EXPERIMENTAL
Intervention: PF-03084014 100 mg twice daily / docetaxel 75 mg/m2
Number of subjects: 29
Study: 26115087

Group type: EXPERIMENTAL
Intervention: High-energy-dense preload (94 kcal/100 g)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Low-energy-dense preload (53 kcal/100 g)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No preload
Number of subjects: 24
Study: 23981966

Group type: EXPERIMENTAL
Intervention: Pemetrexed plus carboplatin with concurrent radiation therapy (PCb)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Pemetrexed plus cisplatin with concurrent radiation therapy (PC)
Number of subjects: 98
Study: 21725230

Group type: EXPERIMENTAL
Intervention: End-to-end (ETE) anastomosis
Number of subjects: 128

Group type: COMPARATOR
Intervention: End-to-side (ETS) anastomosis
Number of subjects: 128
Study: 19180356

Group type: EXPERIMENTAL
Intervention: Vitamin-fortified water (VW)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standardized mixed meal (MM)
Number of subjects: 12
Study: 17716376

Group type: EXPERIMENTAL
Intervention: 8-week lifestyle modification program based on the Choose to Move program; includes audio-taped activity instructions and educational package delivered in weekly home visits.
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: 8-week lifestyle modification program based on the Choose to Move program.
Number of subjects: 335

Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 335
Study: 14767257

Group type: EXPERIMENTAL
Intervention: Gorging (GOR) feeding pattern
Number of subjects: 8

Group type: COMPARATOR
Intervention: Nibbling (NIB) feeding pattern
Number of subjects: 8
Study: 11476107

Group type: EXPERIMENTAL
Intervention: Stanozolol 2 mg twice daily along with cetrizine 10 mg daily
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo tablets twice daily along with cetrizine 10 mg daily
Number of subjects: 58
Study: 11378602

Group type: EXPERIMENTAL
Intervention: Waterless handrub containing 61% ethanol with emollients (ALC)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 2% chlorhexidine gluconate (CHG)‐containing traditional antiseptic wash
Number of subjects: 50
Study: 9433364

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 16 mg inhaled daily for 6 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 8492283

Group type: EXPERIMENTAL
Intervention: Bibliotherapy (written protocol outlining behavioral techniques)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Stimulant medication
Number of subjects: 0
Study: 3303001

Group type: EXPERIMENTAL
Intervention: High-dose metoclopramide (8 mg/kg over 7 hours) and chlorpromazine (50 mg orally)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Reduced dose of metoclopramide (6 mg/kg over 7 hours) and chlorpromazine (50 mg orally)
Number of subjects: 20
Study: 2334619

Group type: EXPERIMENTAL
Intervention: i.v. metoclopramide 10 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: i.m. metoclopramide 10 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: oral diazepam 10 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: i.m. morphine 10 mg
Number of subjects: 40
Study: 4416311

Group type: EXPERIMENTAL
Intervention: Halothane vaporized into the oxygenator at concentrations of 1.0‐1.5%
Number of subjects: 52

Group type: COMPARATOR
Intervention: Diazepam 5‐10 mg supplied into the oxygenator
Number of subjects: 52
Study: 31917894

Group type: EXPERIMENTAL
Intervention: High-performance washer with high-volume, high-pressure nozzles, heated wash water, and improved filtration system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional crate washing system
Number of subjects: 0
Study: 31374452

Group type: EXPERIMENTAL
Intervention: Move More Pack (print-based intervention)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Move More Pack (Internet tools)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Move More Pack (printed components)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Move More Pack (general use)
Number of subjects: 181
Study: 29087880

Group type: EXPERIMENTAL
Intervention: Gabapentin 300 mg before surgery, then three times daily for 6 doses
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 25600169

Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei (LP)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Lactobacillus fermentum (LF)
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Lactobacillus paracasei (LP) + Lactobacillus fermentum (LF) mixture
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Probiotic groups (LP, LF, LP + LF mixture)
Number of subjects: 220
Study: 23281174

Group type: EXPERIMENTAL
Intervention: Morphine and Alcohol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22452896

Group type: EXPERIMENTAL
Intervention: Afatinib (50 mg per day)
Number of subjects: 697

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 697
Study: 19413595

Group type: EXPERIMENTAL
Intervention: Sodium nitroprusside (SNP) infusion (0.5 to 2 microg/kg per min for 30 min)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral extended-release isosorbide mononitrate (120 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Pentaerythritol tetranitrate (160 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 17298881

Group type: EXPERIMENTAL
Intervention: 0.75 microg/day ED-71 for 12 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.5, 0.75 and 1.0 microg/day ED-71 for 12 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 0.75 and 1.0 microg/day ED-71 combined
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15379144

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 54

Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 54
Study: 12439917

Group type: EXPERIMENTAL
Intervention: Intraperitoneal thermochemotherapy and intraperitoneal IL-2 immunotherapy (10 million IU in 500 ml 0.9% sodium chloride daily for 10 times)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Intraperitoneal thermochemotherapy
Number of subjects: 138
Study: 9817305

Group type: EXPERIMENTAL
Intervention: Tacrolimus and prednisone with mycophenolate mofetil (2 gm daily)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Tacrolimus and prednisone without mycophenolate mofetil
Number of subjects: 120
Study: 8929935

Group type: EXPERIMENTAL
Intervention: Comprehensive array of substance-abuse treatment services
Number of subjects: 323

Group type: COMPARATOR
Intervention: Intensive case management in addition to other services
Number of subjects: 323
Study: 2930809

Group type: EXPERIMENTAL
Intervention: Scopolamine (3.0 mu/kg and 6.0 micrograms/kg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 8
Study: 328327

Group type: EXPERIMENTAL
Intervention: 20 mg HBB
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 50 mg HBB
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31826725

Group type: EXPERIMENTAL
Intervention: Low- to moderate-intensity statins
Number of subjects: 2153

Group type: EXPERIMENTAL
Intervention: High-intensity statins
Number of subjects: 2153

Group type: COMPARATOR
Intervention: Statin use (any intensity)
Number of subjects: 2153
Study: 28167511

Group type: EXPERIMENTAL
Intervention: Monthly financial incentives contingent on observed breastfeeding for 6 months (amount increased from $20 to $70, total possible $270)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Usual WIC services only
Number of subjects: 36
Study: 25070944

Group type: EXPERIMENTAL
Intervention: Cumulated fluid balance
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Bland-Altman plots
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Pearson correlations
Number of subjects: 113
Study: 23415672

Group type: EXPERIMENTAL
Intervention: Simultaneous cisplatin radiochemotherapy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Sequential systemic carboplatin and paclitaxel followed by percutaneous irradiation
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: TIMP2 expression in serum
Number of subjects: 68
Study: 21819530

Group type: EXPERIMENTAL
Intervention: SQV/r 2000/100 mg
Number of subjects: 123

Group type: COMPARATOR
Intervention: ATV/r 300/100 mg
Number of subjects: 123
Study: 19726386

Group type: EXPERIMENTAL
Intervention: Strength- or weight-training exercise (SWTE) intervention
Number of subjects: 85
Study: 17322178

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy (including disulfiram, naltrexone, acamprosate)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Monthly, extended-release formulation of naltrexone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Psychosocial therapy
Number of subjects: 0
Study: 15457417

Group type: EXPERIMENTAL
Intervention: Metal liners
Number of subjects: 193

Group type: COMPARATOR
Intervention: Polyethylene liners
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 193